NCT03003689

Brief Summary

Dental bacterial plaque is the most frequent modifiable finding in patients with periodontal (gum) diseases. Many studies have provided evidence that mechanical removal of dental plaque is critical for improving the periodontal health. The standard initial treatment of periodontitis (gum disease) is to remove plaque and calculus form the teeth and root structures using sclaing and root planing (SRP). Typically hand instruments and an ultrasonic scaler are used for SRP While this method removes some of the bacteria that leads to periodontitis, microorganisms are not completely eliminated through SRP. Studies have shown that after 3 months, the bacteria initially present prior to scaling and root planing had recolonized. In order to prevent recurrence of periodontitis, it is recommended that oral bacteria be kept at low levels. When used at the proper wave length, dental lasers have been shown to effectively removes calculus, without damaging surrounding tissue. The Er:YAG laser has been FDA-approved for the use of scaling and root planing in Dentistry. While studies on the Er:YAG laser have shown that it is effective in removing calculus and preserving the tooth root structure, there is no consensus of the level of calculus removal. The Er:YAG laser may also be more effective in removing microbial bacteria than SRP with hand instruments and ultrasonic scaler. The purpose of this study is to evaluate the effectiveness of the Er:YAG laser, as an adjunct to scaling and root planing, in removing microbial bacteria. Participants with chronic periodontitis will be randomized to have one quadrant undergo scaling and root planing using hand instruments and ultrasonic scaler alone, while a second quadrant will receive the same treatment, with the addition of the Er:YAG laser. Outcomes studies will be traditional periodontal clinical parameters at 6 weeks and 3 months after treatment. Microbial cultures will be performed at baseline and 3 months to compare survival and re-population by periodontal microorganisms.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
56

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2017

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 9, 2016

Completed
19 days until next milestone

First Posted

Study publicly available on registry

December 28, 2016

Completed
4 months until next milestone

Study Start

First participant enrolled

April 20, 2017

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2018

Completed
Last Updated

January 11, 2018

Status Verified

January 1, 2018

Enrollment Period

11 months

First QC Date

December 9, 2016

Last Update Submit

January 9, 2018

Conditions

Keywords

Scaling and Root PlaningEr:YAG

Outcome Measures

Primary Outcomes (2)

  • Change in Probing Depth

    Differences in pocket depth reduction between laser treatment and control groups will be analyzed with a linear mixed effects model. Four sites (mesiolingual, mesiobuccal, distolingual, and distobuccal) per tooth will be averaged and used in the linear mixed effects model. Normality of the data will be assessed graphically and with the Shapiro-Wilk test.

    Up to 3 months

  • Change in Clinical Attachment Levels

    Differences in attachment gain between laser treatment and control groups will be analyzed with a linear mixed effects model. Four sites (mesiolingual, mesiobuccal, distolingual, and distobuccal) per tooth will be averaged and used in the linear mixed effects model. Normality of the data will be assessed graphically and with the Shapiro-Wilk test.

    Up to 3 months

Secondary Outcomes (3)

  • Change in Gingival Bleeding Index

    Up to 3 months

  • Change in Plaque Index

    Up to 3 months

  • Change in microbial load, measured in Colony Forming Units (CFUs)

    baseline, 3 months

Study Arms (2)

Scaling and Root Planing

ACTIVE COMPARATOR

Hand instruments + ultrasonic scaler PD, CAL, plaque index and gingival bleeding index will be measured at baseline, 6 weeks and 3 months. Microbial load will be measured at baseline and 3 months.

Procedure: Scaling and Root Planing

Scaling and Root Planing + Er:YAG Laser

EXPERIMENTAL

Er:YAG Laser, hand instruments + ultrasonic scaler PD, CAL, plaque index and gingival bleeding index will be measured at baseline, 6 weeks and 3 months. Microbial load will be measured at baseline and 3 months.

Procedure: Scaling and Root PlaningDevice: Er:YAG Laser

Interventions

Standard of care scaling and root planing using hand instruments and ultrasonic scaler

Scaling and Root PlaningScaling and Root Planing + Er:YAG Laser

Er:YAG laser as an adjunct therapy to standard of care scaling and root planing using hand instruments and ultrasonic

Scaling and Root Planing + Er:YAG Laser

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients enrolled in the Post-Graduate Periodontology Clinic at Tufts University School of Dental Medicine (TUSDM)
  • Recent (within the past 30 days) diagnosis of moderate to severe chronic periodontitis in at least two quadrants according to the Armitage Classification
  • Have had full mouth and vertical bite-wing series of diagnostic radiographs exposed at TUSDM within 6 months preceding entry of the study as a standard of care
  • Have a treatment plan made by the original provider and certified by the PI based on the working diagnosis, presenting etiology, and the predicted therapeutic outcomes of the case (prognosis).
  • Each of the two selected quadrants should have at least 5 teeth including the canine, first premolar and second premolar in contact with at least one tooth that has ≥ 5 mms and ≤ 9 mms probing depths with bleeding on probing.

You may not qualify if:

  • Participants must not have had mechanical debridement or any other professional periodontal therapy within 6 months preceding entering the study
  • Participants with significant chronic oral soft tissue pathology (lichen planus, Benign Mucous Membrane Pemphigoid, Steven Johnson's Syndrome, Sjogren's Syndrome, etc.) which might affect host response to the presence of bacteria.
  • Participants with fixed appliances or partial dentures, to standardize the effect of the treatment since they are plaque retentive.
  • Participants who smoke tobacco
  • Participants who require prophylactic antibiotics prior to dental treatment
  • Participants who have taken systemic antibiotic medications within the previous 6 months
  • Participants with uncontrolled systemic conditions or disease such as diabetes and immunological disorders
  • Participants with known drug allergies or known adverse effects following the use of oral hygiene products.
  • Participants who are pregnant or lactating
  • Teeth with grade III mobility or teeth with hopeless prognosis indicated for extraction

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tufts University School of Dental Medicine

Boston, Massachusetts, 02111, United States

RECRUITING

MeSH Terms

Conditions

Chronic Periodontitis

Interventions

Tooth ExfoliationRoot PlaningLasers, Solid-State

Condition Hierarchy (Ancestors)

PeriodontitisPeriodontal DiseasesMouth DiseasesStomatognathic DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Dental Physiological PhenomenaDigestive System and Oral Physiological PhenomenaDental ScalingDental ProphylaxisPeriodonticsDentistrySubgingival CurettagePreventive DentistryLasersOptical DevicesEquipment and SuppliesRadiation Equipment and Supplies

Study Officials

  • Charles Hawley, DDS, MS, PhD

    TUSDM

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 9, 2016

First Posted

December 28, 2016

Study Start

April 20, 2017

Primary Completion

March 1, 2018

Study Completion

March 1, 2018

Last Updated

January 11, 2018

Record last verified: 2018-01

Data Sharing

IPD Sharing
Will not share

Locations